OF MICE, MEN AND VACCINES
While Dr Theiler's early work at Harvard focused on amoebic dysentery and rat bite fever, he soon developed an enduring interest in yellow fever. In 1927, he and his colleagues began to tackle the controversy regarding its aetiology, complementing ongoing studies at the Rockefeller Foundation in New York, US, the premier centre of yellow fever research at that time. He provided proof that the cause of the disease was not a bacterium but a virus, confirming the findings of Dr James Carroll, a colleague of Dr Walter Reed's, that a filterable agent present in blood -compatible with a virus -was the causative agent. In 1930, Dr Theiler relocated to the International Health Division of the Rockefeller Foundation, where he stayed for about 30 years, thriving in this paradise of scientific experimentation and cutting-edge research.
One of Dr Theiler's main contributions was his demonstration that the yellow fever virus could be easily transmitted to mice. Before this finding, monkeys served as the primary experimental animal. The availability of mice made this a simple solution to greatly reduce costs, improve efficiency and, ultimately, produce a vaccine. He developed a convenient test for detecting protective yellow fever antibodies, which would enable the development of human yellow fever vaccines. Dr Theiler and his colleagues also found that passing the disease from mouse to mouse weakened the virus; this finding subsequently formed the basis for two separate vaccines. The first was a weakened strain used in the 1930s and 1940s by the French government to protect the residents of French territories in Western Africa. The second and improved version, known as 17D, was grown in chicken embryos and was more effective and easier to mass-produce. The launch of this new vaccine took place in Brazil in 1938, and it proved to be highly successful. Within a few years, the Rockefeller Foundation provided millions of doses of the vaccine to people in endemic countries. Over the 60 years that followed, more than 400 million doses of the 17D virus vaccine were administered. This safe and effective vaccine is still produced today by essentially the same methods that Dr Theiler and his colleagues had used.
A NOBEL PRIZE Dr Theiler was first nominated for the Nobel Prize in Physiology or Medicine in 1937, but was not awarded the Nobel Prize until 14 years later. After over a decade in which Dr Theiler was a 'close runner-up', all but two of the Nobel Prize committee members finally agreed to award him the prize in 1951. The two disagreeing members felt that it should have been given to Dr Selman A Waksman for his discovery of streptomycin, the first antibiotic effective against tuberculosis. Dr Theiler received his Nobel Prize based on only three nominations, in contrast to the 39 nominations Dr Waksman had accumulated over six years. Dr Albert Sabin, the father of the live polio vaccine and an influential voice, is believed to have played a dispositive role for Dr Theiler with his nominating letter written in 1948.
In Dr Theiler's speech at the Nobel Banquet in Stockholm, Sweden, on 10 December 1951, he described the evolution of yellow fever research and announced that the conquest of this disease had been one of the great epics in medical history. With graciousness and humility, Dr Theiler focused much of his speech on the work of others rather than himself. 
D I S C O V E R I E S B E YO N D Y E L L O W F E V E R
In the year of Dr Theiler's Nobel Prize win, he became the Director of Laboratories of the Rockefeller Foundation's Division of Medicine and Public Health. His work and contributions extended to many other infectious diseases such as Weil's disease, dengue fever and Japanese encephalitis. The problem of poliomyelitis had been one of his special interests, and he succeeded in discovering the aetiologic agent in an almost identical disorder in laboratory mice. The virus, known as Theiler's murine encephalomyelitis virus, is the cause of mice encephalomyelitis, sometimes referred to as Theiler's disease.
Dr Theiler contributed to many journal articles, which were mostly published in The American Journal of Tropical Medicine and Annals of Tropical Medicine and Parasitology. He also wrote chapters in two books, Viral and Rickettsial Infections of Man (1948) and Yellow Fever (1951) . In addition to the Nobel Prize, Dr Theiler received many other awards throughout his career, including the Chalmers Medal of the Royal Society of Tropical Medicine and Hygiene (1939), the Flattery Medal (1945) and the Lasker Award (1949). A humble man at heart, Dr Theiler remained self-aware about his worth and hard work amid the accolades. He was considered a man of paradoxes, as he often contradicted himself when discussing his achievements and his conditions for 'good science'. For example, he would argue that he had not done anything fundamental and that he did not have any background for making essential theoretical contributions. Yet, he also made it clear that it was he alone who took the essential initiatives in the experiments that led to the development of the vaccine.
THE MAN BEHIND THE SCIENTIST
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